Advertisement

Topics

University of Dundee partners with Takeda to develop new treatments for tau pathology

21:47 EST 19 Feb 2019 | News-Medical.net

The University of Dundee Drug Discovery Unit has announced a partnership with Takeda, Japan's largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in several forms of neurodegeneration, including Alzheimer's disease.

Original Article: University of Dundee partners with Takeda to develop new treatments for tau pathology

NEXT ARTICLE

More From BioPortfolio on "University of Dundee partners with Takeda to develop new treatments for tau pathology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...